The European Union will make pharmaceutical companies respect contracts they have signed for the supply of Covid-19 vaccines, European Council president Charles Michel said on Sunday.
Pfizer last week said it was temporarily slowing supplies to Europe to make manufacturing changes that would boost output. On Friday, AstraZeneca also said that initial deliveries to the region will fall short because of a production glitch.
“We plan to make the pharmaceutical companies respect the contracts they have signed . . . by using the legal means at our disposal,” Mr Michel said on Europe 1 radio.
He did not mention possible sanctions but said the EU would insist on transparency about the reasons for the delays.